Demidova, Elena V.
Serebriiskii, Ilya G.
Vlasenkova, Ramilia
Kelow, Simon
Andrake, Mark D.
Hartman, Tiffiney R.
Kent, Tatiana
Virtucio, James
Rosen, Gail L.
Pomerantz, Richard T.
Dunbrack, Roland L. Jr.
Golemis, Erica A.
Hall, Michael J.
Chen, David Y. T.
Daly, Mary B.
Arora, Sanjeevani
Funding for this research was provided by:
U.S. Department of Defense (W81XWH-18-1-0148, W81XWH-18-1-0148)
Kazan Federal University Strategic Academic Leadership Program (PRIORITY-2030, PRIORITY-2030)
NCI Core Grant (P30 CA006927, P30 CA006927, P30 CA006927, P30 CA006927)
NIH (1R01GM130889, R35 GM122517, R01 DK108195, U01 CA164920, 1UH2CA271230-01)
American Cancer Society
CEP Award from the Yale Head and Neck Cancer SPORE
National Science Foundation, United States (#1919691, #1936782, and #2107108)
Article History
Received: 19 August 2022
Accepted: 13 April 2023
First Online: 24 April 2023
Change Date: 10 July 2023
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1186/s12864-023-09486-z
Declarations
:
: The FCCC Institutional Review Board Committee provided study oversight and approval (protocol number 14–831). The FCCC IRB determined the criteria for the approval of research outlined in 45 CFR 46.111. All experiments using human biospecimens were performed in accordance with relevant guidelines and regulations. Blood samples were banked in the FCCC Biosample Repository Facility under broad informed consent for research and deidentified.
: Not applicable.
: All authors declare that there is no competing interest regarding this manuscript. M.J.H. performs collaborative research (with no funding) with the following: Myriad Genetics, Invitae Corporation, Ambry Genetics, Foundation Medicine, Inc. He also performs collaborative research (with no funding) and is part of a Precision Oncology Alliance funded by Caris Life Sciences (cover travel and meals at meetings). S.A. performs collaborative research (with no funding) with Caris Life Sciences, Foundation Medicine, Inc., Ambry Genetics, and Invitae Corporation. S.A.’s spouse is employed by Akoya Biosciences and has stocks in Akoya Biosciences, HTG Molecular Diagnostics, Abcam Plc., and Senzo Health. S.A., M.J.H., E.A.G., I.G.S. have patents and/or pending patents related to cancer diagnostics/treatment.